115 related articles for article (PubMed ID: 38700461)
41. The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients.
Abe T; Jujo K; Maeda D; Saito K; Ogasahara Y; Saito K; Saito H; Iwata K; Konishi M; Kitai T; Kasai T; Wada H; Momomura SI; Kagiyama N; Kamiya K; Yamashita M; Hamazaki N; Nozaki K; Maekawa E; Ako J; Matsue Y
ESC Heart Fail; 2023 Jun; 10(3):1698-1705. PubMed ID: 36824014
[TBL] [Abstract][Full Text] [Related]
42. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
[TBL] [Abstract][Full Text] [Related]
43. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
[TBL] [Abstract][Full Text] [Related]
44. Frailty and Hospitalization Burden in Patients With Chronic Heart Failure.
Mollar A; Bonanad C; Diez-Villanueva P; Segarra D; Civera J; Sastre C; Conesa A; Villaescusa A; Fernández J; Miñana G; Navarro J; Sanchis J; Núñez J
Am J Cardiol; 2022 Nov; 183():48-54. PubMed ID: 36153181
[TBL] [Abstract][Full Text] [Related]
45. Association of Frailty With 30-Day Outcomes for Acute Myocardial Infarction, Heart Failure, and Pneumonia Among Elderly Adults.
Kundi H; Wadhera RK; Strom JB; Valsdottir LR; Shen C; Kazi DS; Yeh RW
JAMA Cardiol; 2019 Nov; 4(11):1084-1091. PubMed ID: 31553402
[TBL] [Abstract][Full Text] [Related]
46. Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.
Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
ESC Heart Fail; 2021 Aug; 8(4):2876-2888. PubMed ID: 34080791
[TBL] [Abstract][Full Text] [Related]
47. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).
Wong CM; Hawkins NM; Jhund PS; MacDonald MR; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; McMurray JJ
J Am Coll Cardiol; 2013 Nov; 62(20):1845-54. PubMed ID: 23850914
[TBL] [Abstract][Full Text] [Related]
48. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
[TBL] [Abstract][Full Text] [Related]
49. Assessment of frailty and related outcomes in older patients with heart failure: A cohort study.
Tournas G; Kourek C; Mantzaraki V; Georgiopoulos G; Pantos C; Toumanidis S; Briasoulis A; Paraskevaidis I
Hellenic J Cardiol; 2022; 67():42-47. PubMed ID: 35469925
[TBL] [Abstract][Full Text] [Related]
50. The hospital frailty risk score in patients with heart failure is strongly associated with outcomes but less so with pharmacotherapy.
McAlister FA; Savu A; Ezekowitz JA; Armstrong PW; Kaul P
J Intern Med; 2020 Mar; 287(3):322-332. PubMed ID: 31661589
[TBL] [Abstract][Full Text] [Related]
51. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
[TBL] [Abstract][Full Text] [Related]
52. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF.
Naser N; Durak-Nalbantic A; Sabanovic-Bajramovic N; Karic A
Med Arch; 2023 Apr; 77(2):105-111. PubMed ID: 37260796
[TBL] [Abstract][Full Text] [Related]
53. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry.
Tomasoni D; Pagnesi M; Colombo G; Chiarito M; Stolfo D; Baldetti L; Lombardi CM; Adamo M; Maggi G; Inciardi RM; Loiacono F; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Rosano G; Sinagra G; Pini D; Savarese G; Metra M
Eur J Heart Fail; 2024 Feb; 26(2):327-337. PubMed ID: 37933210
[TBL] [Abstract][Full Text] [Related]
54. Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries.
Ouwerkerk W; Teng TK; Tromp J; Tay WT; Cleland JG; van Veldhuisen DJ; Dickstein K; Ng LL; Lang CC; Anker SD; Zannad F; Hung CL; Sawhney JPS; Naik A; Shimizu W; Hagiwara N; Wander GS; Anand I; Richards AM; Voors AA; Lam CSP
Eur J Heart Fail; 2020 Aug; 22(8):1472-1482. PubMed ID: 32583922
[TBL] [Abstract][Full Text] [Related]
55. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
[TBL] [Abstract][Full Text] [Related]
56. Changes in frailty and incident cardiovascular disease in three prospective cohorts.
He D; Wang Z; Li J; Yu K; He Y; He X; Liu Y; Li Y; Fu R; Zhou D; Zhu Y
Eur Heart J; 2024 Mar; 45(12):1058-1068. PubMed ID: 38241094
[TBL] [Abstract][Full Text] [Related]
57. Frailty and risk for heart failure in older adults: the health, aging, and body composition study.
Khan H; Kalogeropoulos AP; Georgiopoulou VV; Newman AB; Harris TB; Rodondi N; Bauer DC; Kritchevsky SB; Butler J
Am Heart J; 2013 Nov; 166(5):887-94. PubMed ID: 24176445
[TBL] [Abstract][Full Text] [Related]
58. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
[TBL] [Abstract][Full Text] [Related]
59. The impact of frailty according to Clinical Frailty Scale on clinical outcome in patients with heart failure.
Kanenawa K; Isotani A; Yamaji K; Nakamura M; Tanaka Y; Hirose-Inui K; Fujioka S; Mori S; Yano M; Ito S; Morinaga T; Fukunaga M; Hyodo M; Ando K
ESC Heart Fail; 2021 Apr; 8(2):1552-1561. PubMed ID: 33547759
[TBL] [Abstract][Full Text] [Related]
60. β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction.
Wang B; Zhang L; Hu S; Bai X; Zhang H; Li X; Li J; Zheng X
Eur Heart J Cardiovasc Pharmacother; 2022 Feb; 8(2):140-148. PubMed ID: 33774652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
